OS Therapies (OSTX) Prepaid Assets (2024 - 2025)
OS Therapies' (OSTX) quarterly Prepaid Assets came in at $63082.0 in Q4 2025, down 84.36% on a QoQ basis from $403213.0 in Q3 2025.
OS Therapies (OSTX) Prepaid Assets (2024 - 2025) Analysis & Trends
OS Therapies (OSTX) has 2 years of Prepaid Assets data on file, last reported at $63082.0 in Q4 2025.
- Quarterly Prepaid Assets changed N/A year-over-year to $63082.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $63082.0 (changed N/A YoY) and the FY2025 annual result came in at $63082.0, changed N/A from the prior year.
- Prepaid Assets fell to $63082.0 in Q4 2025, from $403213.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $1.1 million in Q1 2025 to a low of $35000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | OS Therapies | 19.31 Mn | 19.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 63,082.00 |
| Sep 30, 2025 | 403,213.00 |
| Jun 30, 2025 | 751,963.00 |
| Mar 31, 2025 | 1.10 Mn |
| Sep 30, 2024 | 35,000.00 |